Immunogenicity of a Fourth Homologous Dose of NVX-CoV2373
N Engl J Med
.
2023 Mar 2;388(9):857-859.
doi: 10.1056/NEJMc2215509.
Epub 2023 Jan 25.
Authors
Katia Alves
1
,
Joyce S Plested
1
,
Shirley Galbiati
1
,
Gordon Chau
1
,
Shane Cloney-Clark
1
,
Mingzhu Zhu
1
,
Raj Kalkeri
1
,
Nita Patel
1
,
Kathy Smith
1
,
Alex Marcheschi
1
,
Susan Pfeiffer
1
,
Heather McFall
1
,
Gale Smith
1
,
Gregory M Glenn
1
,
Filip Dubovsky
1
,
Raburn M Mallory
1
;
Novavax 2019nCoV-101 Study Group
Affiliation
1
Novavax, Gaithersburg, MD
[email protected]
.
PMID:
36734884
PMCID:
PMC9891358
DOI:
10.1056/NEJMc2215509
No abstract available
Publication types
Letter
MeSH terms
COVID-19 Vaccines* / administration & dosage
COVID-19 Vaccines* / immunology
Humans
Immunogenicity, Vaccine* / immunology
Substances
COVID-19 Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle